In this article, the authors provide an up-to-date review of all reported genomic aberrations in the eight most common pediatric solid tumors with whole-exome sequencing or whole-genome sequencing data.
Browsing: Disease Area > Rare tumors
In this patient perspective article, you can find out about the challenges associated with diagnosing mesothelioma and the promising role that biomarkers are playing.
Editor, Jade Parker recently spoke with world-renowned sarcoma expert, Robin L Jones. In this interview discover challenges in the diagnosis, treatment and clinical trials of sarcoma and other rare tumors.
Targeted sequencing focused on cancer-related genes provides comprehensive assessment of tumor mutational burden, with results comparable to whole-exome sequencing.
According to a new American Cancer Society Report, one in five cancer diagnoses in the United States is a rare cancer.
A commentry of brain tumors associated with Li-Fraumeni syndrome, followed by a case report of the development of a rare gliosarcoma in a Li-Fraumeni patient
Researchers have identified previously ignored mutations that, despite being rare, are likely associated with cancer growth. The discovery may lead to the development of new targeted therapies.
Lydia Makaroff of the European Cancer Patient Coalition (ECPC, Brussels, Belgium) speaks with Oncology Central about the goals and upcoming projects for the ECPC in 2017.
This review article from Future Oncology summarizes the efficacy of the latest therapeutic agents available for the treatment of patients with relapsed multiple myeloma.
This case report details a rare example of a woman with metastatic and rapidly progressive secretory paraganglioma who responded rapidly and durably to lenvatinib.